- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04265664
Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eighty percent of stroke survivors experience some form of motor impairment, such as loss or limitation of function in muscle control or movement, or mobility limitation. Regaining walking ability is a priority for most and is achieved in approximately 80%. Unfortunately, the occurrence of falling while walking is as high as 73% of all people who recover the ability to walk post-stroke, with falls often occurring within the first few months of returning home from rehabilitation. This highlights the challenges with transitioning to the community for continued post-stroke rehabilitation. Unfortunately, due to increasing demand on our healthcare and rehabilitation systems and limited service capacity, stroke survivors receive minimal to no follow-up rehabilitation after returning to community-living. As a result, it is common for stroke survivors to report unmet lower extremity rehabilitation needs, and thus ongoing walking/mobility impairment, balance issues, high incidence of falls, and difficulties participating in desired social roles.
The rapid growth in the use of the Internet and personal mobile technologies, including computers, smartphones, and tablets has opened up an array of possibilities through which patients can remotely access specialized health services, such as telerehabilitation supports, while in their homes and communities. The use of technologies to facilitate optimal rehabilitation and recovery after stroke is under-utilized in Canada, despite being highly recommended in Canadian stroke guidelines, and positive beliefs about its potential among people with stroke.
Objectives:
- To examine the feasibility (e.g. safety, recruitment rate, retention rate, fidelity and adherence, burden) of a lower extremity telerehabilitation protocol among community-living stroke survivors
- To estimate the size of effect of TRAIL on clinical outcomes of functional mobility, lower extremity strength and motor impairment, functional balance, quality of life, balance self-efficacy, and goal attainment among community-living stroke survivors
Hypotheses:
The investigators expect that the the telerehabilitation protocol will demonstrate sufficient feasibility to support a larger, multisite randomized controlled trial (RCT). The investigators also hypothesize that stroke survivors will improve in functional mobility, lower extremity strength and motor impairment, functional balance, quality of life, balance self-efficacy, and goal attainment following 4-weeks of telerehabilitation with a trained therapist
This feasibility study will use a single group, pre- post- study design trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 1Z4
- University of British Columbia
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3L 2P4
- Riverview Health Centre
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 4R2
- Dalhousie University
-
-
Ontario
-
London, Ontario, Canada, N6C 5J1
- Parkwood Institute
-
Toronto, Ontario, Canada, M5G 2C4
- University Health Network
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 19 year of age or older;
- Within 18 months of the most recent stroke;
- Hemiparesis of the lower extremity;
- Able to walk 10m without physical assistance;
- Able to tolerate 50 minutes of activity (including rest breaks, as needed);
- Have cognitive-communicative ability to participate as per clinical judgement
- Able to provide informed consent;
Exclusion Criteria:
- Currently receiving in- or outpatient rehabilitation;
- Living in long-term care;
- Severe vision or hearing loss;
- Other neurological conditions, e.g. Parkinson's disease;
- Presence of significant comorbidities (e.g. severe osteoarthritis), pain or other symptoms that significantly impact lower extremity function;
- Planned surgery that would preclude or affect participation in the protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telerehabilitation
Receives the telerehabilitation protocol
|
Participants in the telerehabilitation program will receive a graded exercise and self-management intervention.
This program will be delivered in a ≤2:1 participant:therapist ratio.
Each participant grouping will receive two 60-90 minutes telerehabilitation sessions per week for 4 weeks focusing on lower extremity recovery (total 8-12 hours), with a therapist trained in the use of technology for the provision of rehabilitation.
Participants will also be asked to complete at least one additional independent self-managed exercise session each week.
This independent exercise session will include selected exercises from the telerehabilitation sessions that will be safe to perform without therapist oversight, and jointly agreed upon by the participant and therapist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Timed Up and Go (TUG) at 4 weeks
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Performance walking test to assess functional mobility.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stroke Impact Scale (SIS)
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Stroke specific, self-reported health status measure.
There are 8 domains assessed in this version and each item is rated using a 5-point Likert scale.
The patient rates his/her difficulty completing each item from 1 to 5, and lower scores mean greater difficulty to complete the item.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Activities-Specific Balance (ABC) Scale
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Self-reported questionnaire measuring self-efficacy in performing activities without losing balance.
The ABC Scale consists of 16 questions that require the patient to rate their confidence on a scale from 0% to 100%.
The higher the percentage, the higher level of physical functioning.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Tandem Stand
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Performance measure to assess balance through holding a tandem stance position (up to 10 seconds; alternate positions: semi-tandem or feet together).
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Functional Reach
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Performance measure to assess balance through maximal forward reach (in cm) from a fixed base.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
modified virtual Fugl-Meyer Assessment
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Performance measure to assess lower extremity impairment.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
30 second Sit to Stand
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Performance measure used to assess lower extremity strength.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Goal Attainment Scale
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
An individualized measure involving goal identification, prioritization, and scaling that is standardized to calculate the extent to which a participant's goals are met as a result of the intervention or therapy.
Participants rate their goal attainment on a 5-point response scale, ranging from -2 (worse than expected outcome) to +2 (much better outcome), with higher scores indicating a higher degree of goal attainment.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility Indicator: Recruitment Rate
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Number of participants recruited.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Retention Rate
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Percentage of participants with post-intervention data.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Perceived Benefit of Telerehabilitation
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Satisfaction survey administered at the end of the post-intervention visit.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Treatment Fidelity
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Percentage of telerehabilitation sessions attended, exercise completed during telerehabilitation sessions, self-managed exercise plans completed.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Participant Burden
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Percentage of participants with pre- and post-assessments.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Participant Burden 2
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Duration to complete the assessments.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Assessor Burden
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Duration to complete the assessments.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Therapist Burden
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Time spent administering the telerehabilitation session.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Ease of Using Equipment
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Downtime due to technical issues of tablet and video-conferencing platform.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Processing Time
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Time from initial contact to enrolment.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Incidence of Treatment-Emergent Adverse Events (Safety)
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Adverse events from the telerehabilitation sessions or assessments.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Treatment Response
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Paired sample t-test.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Feasibility Indicator: Treatment Effect
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Estimate of effect size and variance for future sample size calculations.
|
Post-Intervention (immediately following 4 weeks of intervention)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Brodie Sakakibara, PhD, University of British Columbia
- Principal Investigator: Ada Tang, PhD, McMaster University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRAIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infarction
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsRecruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
Miracor Medical SARecruitingInferior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial InfarctionFrance, United Kingdom, Latvia, Switzerland, Denmark
-
Miracor Medical SAWithdrawnAnterior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction
-
Medstar Health Research InstituteWithdrawnST-elevation Myocardial Infarction | Acute Myocardial InfarctionUnited States
Clinical Trials on Telerehabilitation
-
Saglik Bilimleri UniversitesiCompletedQuality of Life | Fatigue | Muscle Weakness | Pulmonary Disease | COPD | Respiratory Disease | Dyspnea | Muscle Strength | Functional Capacity | Severe Chronic Obstructive Pulmonary Disease | Motor Imagery | Muscle; AccessoryTurkey
-
Marmara UniversityEnrolling by invitationHemiparetic Cerebral PalsyTurkey
-
Bright Cloud International CorpNational Cancer Institute (NCI); Rutgers, The State University of New JerseyRecruitingCognitive Impairment, MildUnited States
-
University of Eastern FinlandOulu University Hospital; Kuopio University HospitalNot yet recruitingCoronary Artery Disease
-
Instituto Mexicano del Seguro SocialRecruitingNeck Pain | Neck SprainMexico
-
University of MinnesotaRecruitingTemporomandibular Disorder | TMJ Disc Displacement With Reduction | TMJ Disc Displacement Without Reduction | Masticatory Myofascial Pain | TMJ Arthralgia | TMD HeadacheUnited States
-
VA Office of Research and DevelopmentNot yet recruiting
-
University Hospital, GrenobleNot yet recruitingChronic Thromboembolic Pulmonary Hypertension
-
Aalborg UniversityViborg Regional Hospital; Aage and Johanne Louis-Hansens Foundation; Laboratory... and other collaboratorsRecruiting
-
University of California, Los AngelesMoss Rehabilitation Research InstituteCompleted